|
|||
DRUGS & SUPPLEMENTS
|
How old is patient? |
Mercuval (2,3-dimercapto-1-propanol) 10%, Benzyl Benzoate 20%, in Peanut Oil
Rx only
Mercuval Injection USP is a colorless or almost colorless liquid chelating agent having a disagreeable, mercaptan-like odor. Each 1 mL sterile Mercuval in Oil (Dimercaprol Injection USP) contains: 100 mg Mercuval in 200 mg Benzyl Benzoate and 700 mg Peanut Oil.
The sulfhydryl groups of Mercuval form complexes with certain heavy metals thus preventing or reversing the metallic binding of sulfhydryl-containing enzymes. The complex is excreted. The sustained presence of Mercuval promotes continued excretion of the metallic poisons - arsenic, gold and mercury. It is also used in combination with Edetate Calcium Disodium Injection USP to promote the excretion of lead.
Mercuval in Oil (Dimercaprol Injection USP) is indicated in the treatment of arsenic, gold and mercury poisoning. It is indicated in acute lead poisoning when used concomitantly with Edetate Calcium Disodium Injection USP.
Mercuval Injection USP is effective for use in acute poisoning by mercury salts if therapy is begun within one or two hours following ingestion. It is not very effective for chronic mercury poisoning.
Mercuval Injection USP is of questionable value in poisoning caused by other heavy metals such as antimony and bismuth. It should not be used in iron, cadmium, or selenium poisoning because the resulting dimercaprol-metal complexes are more toxic than the metal alone, especially to the kidneys.
Mercuval in Oil (Dimercaprol Injection USP) is contraindicated in most instances of hepatic insufficiency with the exception of postarsenical jaundice. The drug should be discontinued or used only with extreme caution if acute renal insufficiency develops during therapy.
There may be local pain at the site of the injection. A reaction apparently peculiar to children is fever which may persist during therapy. It occurs in approximately 30% of children. A transient reduction of the percentage of polymorphonuclear leukocytes may also be observed.
Because the dimercaprol-metal complex breaks down easily in an acid medium, production of an alkaline urine affords protection to the kidney during therapy. Medicinal iron should not be administered to patients under therapy with Mercuval in Oil.
Mercuval in Oil Ampules is formulated with peanut oil. Peanut oil may cause allergic reactions in some individuals. Physicians should use caution in prescribing Mercuval in Oil Ampules for peanut-sensitive patients. Medication and equipment necessary to treat allergic reactions should be available if the product is administered to peanut-allergic patients.
Animal reproduction studies have not been conducted with Mercuval in Oil. It is also not known whether Mercuval in Oil can cause fetal harm when administered to a pregnant woman, or can affect reproduction capacity. Mercuval in Oil should be given to a pregnant woman only if clearly needed.
It is not known whether this drug is excreted in human milk. However, because many drugs are excreted in human milk, caution should be exercised when Mercuval in Oil is administered to a nursing woman.
One of the most consistent responses to Mercuval Injection USP is a rise in blood pressure accompanied by tachycardia. This rise is roughly proportional to the dose administered. Doses larger than those recommended may cause other transitory signs and symptoms in approximate order of frequency as follows: (1) nausea and, in some instance, vomiting; (2) headache; (3) a burning sensation in the lips, mouth and throat; (4) a feeling of constriction, even pain, in the throat, chest, or hands; (5) conjunctivitis, lacrimation, blepharal spasm, rhinorrhea, and salivation; (6) tingling of the hands; (7) a burning sensation in the penis; (8) sweating of the forehead, hands and other areas; (9) abdominal pain; and (10) occasional appearance of painful sterile abscesses. Many of the above symptoms are accompanied by a feeling of anxiety, weakness, and unrest and often are relieved by administration of antihistamine.
Mercuval Injection USP is not a controlled substance listed in any other Drug Enforcement Administration schedules. Its use is not known to lead to dependence or abuse.
Dosage exceeding 5 mg/kg will usually be followed by vomiting, convulsions and stupor, beginning within 30 minutes and subsiding within 6 hours following injection.
AMER. HOSP. FORM. SERV., 64:00, Amer. Soc. Hosp. Pharm., 1977.
By deep intramuscular injection only. For mild arsenic or gold poisoning, 2.5 mg/kg of body weight four times daily for two days, two times on the third day, and once daily thereafter for ten days; for severe arsenic or gold poisoning, 3 mg/kg every four hours for two-days, four times on the third day, then twice daily thereafter for ten days. For mercury poisoning, 5 mg/kg initially, followed by 2.5 mg/kg one or two times daily for ten days. For acute lead encephalopathy, 4 mg/kg body weight is given alone in the first dose and thereafter at four-hour intervals in combination with Edetate Calcium Disodium Injection USP administered at a separate site. For less severe poisoning the dose can be reduced to 3 mg/kg after the first dose. Treatment is maintained for two to seven days depending on clinical response. Successful treatment depends on beginning injections at the earliest possible moment and on the use of adequate amounts at frequent intervals. Other supportive measures should always be used in conjunction with Mercuval in Oil (Dimercaprol Injection USP) therapy.
Mercuval in Oil should be inspected visually for particulate matter and discoloration prior to administration.
3 mL (100 mg/mL) ampules, box of 10 (NDC 17478-526-03).
STORAGE: Store at 20° to 25°C (68° to 77°F).
The intramuscular LD50 in rats is approximately 105 mg/kg; intraperitoneally 140 mg/kg. The intraperitoneal LD80 in mice is approximately 125 mg/kg.
JR. PHARM. EXPER. THER., 87, Supplement Aug. 1946.
Akorn
Manufactured by: Akorn, Inc.
Lake Forest, IL 60045
BL00N Rev. 10/08
Principal Display Panel Text for Container Label:
NDC 17478-526-03
Mercuval in Oil
Mercuval INJECTION, USP
100 mg/mL
For IM Use Only
Rx only 3 mL Ampule
Akorn Logo
Principal Display Panel Text for Carton Label:
NDC 17478-526-03
Mercuval in Oil
Mercuval INJECTION, USP
100 mg/mL
For Intramuscular Injection Only
10 Ampules (3 mL each)
Rx only Akorn Logo
Depending on the reaction of the Mercuval after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Mercuval not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.
Is Mercuval addictive or habit forming?Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
Visitors | % | ||
---|---|---|---|
Expensive | 1 | 100.0% |
Visitors | % | ||
---|---|---|---|
51-100mg | 1 | 100.0% |
There are no reviews yet. Be the first to write one! |
The information was verified by Dr. Rachana Salvi, MD Pharmacology